Morey & Quinn Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Buy
11,625
+38
+0.3% +$2.06K 0.32% 74
2026
Q1
$727K Buy
11,587
+160
+1% +$12.8K 0.52% 50
2025
Q4
$1.09M Sell
11,427
-104
-0.9% -$10.2K 0.78% 29
2025
Q3
$1.13M Sell
11,531
-500
-4% -$51.8K 0.83% 28
2025
Q2
$1.29M Sell
12,031
-493
-4% -$49.9K 1.03% 20
2025
Q1
$1.26M Sell
12,524
-163
-1% -$16.4K 1.05% 22
2024
Q4
$1.13M Buy
+12,687
New +$1.12M 0.96% 24

Other funds holding BSX

Morey & Quinn Wealth Partners's BSX Position: Q2 2026 in Review

Morey & Quinn Wealth Partners increased its Boston Scientific (BSX) stake by 0.33% in Q2 2026, buying an estimated $2.06K and bringing the position to 11,625 shares worth $496K. The position accounts for 0.32% of the portfolio, ranked #74.

Morey & Quinn Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.29M in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Morey & Quinn Wealth Partners held 11,625 shares of Boston Scientific worth $496K as of Q2 2026.
  • Morey & Quinn Wealth Partners bought 38 Boston Scientific shares in Q2 2026, an estimated $2.06K.
  • Boston Scientific made up 0.32% of Morey & Quinn Wealth Partners's portfolio in Q2 2026, its #74 holding.
  • Morey & Quinn Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Morey & Quinn Wealth Partners's Boston Scientific position peaked at $1.29M in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Morey & Quinn Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.